If you're attending #ADLM, come learn more about our novel diagnostic tool that distinguishes between bacterial and viral infections in just 15 minutes, at our partner Diasorin's booth through engaging in-booth presentations. Don't miss out on insights from top medical experts. Here's the schedule: 📅 Tuesday, July 30th 11 AM: "Loyola University Medical Center Real-World Experience with the FDA-Approved LIAISON® MeMed BV®" - Join Mark E Cichon, DO, and David M Engman, MD, PhD, as they share valuable experiences and outcomes. 📅 Wednesday, July 31st 11 AM: Dive deeper into the real-world applications of the LIAISON® MeMed BV® at Loyola University Medical Center with Mark E Cichon, DO, and David M Engman, MD, PhD. 2 PM: "Strategies for Enlisting Clinician Advocates for a New FDA-Approved Diagnostic Test: Lessons from LIAISON® MeMed BV®" - Don’t miss Dr. David Engman, MD, PhD, as he outlines effective strategies for clinician engagement and advocacy. 📍 Location: Booth #1424 #ADLM #HealthcareInnovation #MedicalDiagnostics #LiaisonMeMedBV
We are two weeks away from ADLM. As you are planning your schedule, remember to keep in mind our engaging in-booth (#1424) presentations: Tuesday, July 30th 10 AM “Advancing translational research using xMAP® Multiplexing Technology: Real-World Applications” with Dr. Gabriela Garcia-Soto, PhD 11 AM “Loyola University Medical Center real-world experience with the FDA-approved LIAISON® MeMed BV®” with Mark E Cichon, DO and David M Engman, MD, PhD 2 PM “Candida auris: An Emerging Threat to Public Health and the First FDA De Novo Granted Molecular Assay for Identifying At-Risk Patients” with Michelle Tabb, PhD 3 PM “Diagnostic Stewardship for Syndromic Respiratory Testing: Flexibility is the Name of the Game” with Kaisha Gonzalez, PhD Wednesday, July 31st 10 AM “Diagnostic Stewardship for Syndromic Respiratory Testing: Flexibility is the Name of the Game” with Kaisha Gonzalez, PhD 11 AM “Loyola University Medical Center real-world experience with the FDA-approved Liaison® MeMed BV®” with Mark E Cichon, DO and David M Engman, MD, PhD 2 PM “Strategies for Enlisting Clinician Advocates for a New FDA-Approved Diagnostic Test: Lessons from LIAISON® MeMed BV®” with Dr. David Engman, MD, PhD 3 PM “Candida auris: An Emerging Threat to Public Health and the First FDA De Novo Granted Molecular Assay for Identifying At-Risk Patients” with Michelle Tabb, PhD #ADLM #xMAPTechnology #diagnosticstewardship #fungalinfections #emergingdiseases #differentialtesting #lifesciences #diagnostictesting #immunodiagnostictesting